T45.AX3 فئة تحتاج إلى مزيد من التحديد Poisoning by immune checkpoint inhibitors and immunostimulant drugs, assault
ICD-10-CM T45.AX3 identifies “Poisoning by immune checkpoint inhibitors and immunostimulant drugs, assault” as a category requiring further specificity in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.
الفصل 19: Injury, poisoning and certain other consequences of external causes
تعليمات الرمز
لا توجد ملاحظات إضافية.
تعليمات المستويات الأعلى
الفصول 19 · Injury, poisoning and certain other consequences of external causes (S00-T88)
Excludes 22
- birth trauma (P10-P15)
- obstetric trauma (O70-O71)
Use additional code1
code to identify any retained foreign body, if applicable (Z18.-)
Note2
- Use secondary code(s) from Chapter 20, External causes of morbidity, to indicate cause of injury. Codes within the T section that include the external cause do not require an additional external cause code
- The chapter uses the S-section for coding different types of injuries related to single body regions and the T-section to cover injuries to unspecified body regions as well as poisoning and certain other consequences of external causes.
T36-T50 · Poisoning by, adverse effects of and underdosing of drugs, medicaments and biological substances (T36-T50)
Includes4
- adverse effect of correct substance properly administered
- poisoning by overdose of substance
- poisoning by wrong substance given or taken in error
- underdosing by (inadvertently) (deliberately) taking less substance than prescribed or instructed
Excludes 11
toxic reaction to local anesthesia in pregnancy (O29.3-)
Excludes 25
Code first7
Use additional code4
Note1
The drug giving rise to the adverse effect should be identified by use of codes from categories T36-T50 with fifth or sixth character 5.
T45 · Poisoning by, adverse effect of and underdosing of primarily systemic and hematological agents, not elsewhere classified
Seventh character1
The appropriate 7th character is to be added to each code from category T45
A — initial encounter
D — subsequent encounter
S — sequela
T45.A · Poisoning by, adverse effect of and underdosing of immune checkpoint inhibitors and immunostimulant drugs
Excludes 11
poisoning by, adverse effect of and underdosing of antineoplastic and immunosuppressive drug (T45.1)
رموز أكثر تحديدًا
T45.AX3APoisoning by immune checkpoint inhibitors and immunostimulant drugs, assault, initial encounterرمز محدد قابل للفوترةT45.AX3DPoisoning by immune checkpoint inhibitors and immunostimulant drugs, assault, subsequent encounterرمز محدد قابل للفوترةT45.AX3SPoisoning by immune checkpoint inhibitors and immunostimulant drugs, assault, sequelaرمز محدد قابل للفوترةمراجع الفهرس الرسمي
مراجع الفهرس الرسمي (2)
Immune (1)
- Immune › checkpoint inhibitorsالأدوية والمواد الكيميائية
Immunostimulant drug (1)
- Immunostimulant drugالأدوية والمواد الكيميائية
السجل
سجل الرمز
آخر تغيير مسجل · FY2025 · 04-01
يسري من
- تغيّرت التعليمات الموروثة
Poisoning by immune checkpoint inhibitors and immunostimulant drugs, assault
فئة — اختر رمزًا أكثر تحديدًا
CDC/NCHS · FY2025 · 04-01جميع الإصدارات (5)
| جميع الإصدارات | يسري من | سجل الرمز |
|---|---|---|
| FY2025 | 2024-10-01 | أُضيف |
| FY2025 · 04-01 | 2025-04-01 | تغيّرت التعليمات الموروثة |
| FY2026 | 2025-10-01 | لا تغيير في القائمة الجدولية |
| FY2026 · April | 2026-04-01 | لا تغيير في القائمة الجدولية |
| FY2027 | 2026-10-01 | لا تغيير في القائمة الجدولية |
استكشف الرموز الأكثر تحديدًا في هذه الفئة. لا يثبت التحقق المرجعي الملاءمة السريرية ولا يضمن التعويض.